Made With Uberflip Content Marketing

Partnering & Drug Development

Life science dealmaking is an ongoing process. EBD Group brings together business development execs from pharma, biotech and investment through our partnering events and online community (partnering360).

  • Starting a biotech company: What every entrepreneur needs to know

    Starting a biotech company: What every entrepreneur needs to know

    Just released: The Biotech Startup Manual. This report distills the insights, wisdom, and inspiration from a carefully selected group of industry pioneers on what it truly takes to start a...

    Read
  • How stakeholder insight adds value to your asset and drug development program

    How stakeholder insight adds value to your asset and drug development program

    Thinking early about market access is something many small and virtual biotech firms don’t automatically think to do, but should. Read more »

    Read
  • EBD Academy brings executive-level leadership skills to you

    EBD Academy brings executive-level leadership skills to you

    Executive education is a critical component of business effectiveness. Business development senior management, executive management, and management teams perform at the highest level of an...

    Read
  • ChinaBio® Partnering Forum 2017: HitGen aids China drug discovery with DNA library7:36

    ChinaBio® Partnering Forum 2017: HitGen aids China drug discovery with DNA library

    Wei Chen, head of R&D for Chengdu-based HitGen describes to Scrip’s Brian Yang how the Chinese startup partners with multinationals to speed up new drug development in China, and planned IND filing fo

    Watch Video
  • ChinaBio® Partnering Forum 2017: Sirnaomics prioritizes China in parallel with US RNAi development15:06

    ChinaBio® Partnering Forum 2017: Sirnaomics prioritizes China in parallel with US RNAi development

    Alan Y. Lu, Executive VP of Sirnaomics, discusses with Scrip’s Brian Yang how the US-China hybrid looks to develop RNAi therapies simultaneously in the two countries. RNAi is relatively new in China,

    Watch Video
  • ChinaBio® Partnering Forum 2017: China's HEC Pharm enters America with novel IPF treatment7:00

    ChinaBio® Partnering Forum 2017: China's HEC Pharm enters America with novel IPF treatment

    Tommy Lin, head of Business Development and Global Licensing for HEC Pharm outlines for Scrip’s Brian Yang how the Chinese domestic drug company looks to develop its liver drug in the US. On May 2, t

    Watch Video
  • ChinaBio® Partnering Forum 2017: China's EpimAb hunts for novel biologics with funding, partnership8:16

    ChinaBio® Partnering Forum 2017: China's EpimAb hunts for novel biologics with funding, partnership

    Dr. Wu Chengbin, CEO and founder of Shanghai-based EpimAb Biotherapeutics discusses with Scrip’s Brian Yang how the startup's preparatory platform will develop next-generation bispecific antibodies.

    Watch Video
  • ChinaBio® Partnering Forum 2017: ConSynance tests waters in China with differentiated NASH asset8:10

    ChinaBio® Partnering Forum 2017: ConSynance tests waters in China with differentiated NASH asset

    Dr. Shuang Liu, president and co-founder of upstate New York-based ConSynance Therapeutics discusses with Scrip’s Brian Yang the startup's plan to develop and commercialize its multiple assets in vari

    Watch Video
  • ChinaBio® Partnering Forum 2017: Roche looks to real-world data and IT to drive partnering in China

    Mark Noguchi, Global Head, Alliance and Asset Management at Roche discusses with Scrip’s Brian Yang the Swiss biotech's plan to tap into emerging IT for partnering opportunities in China. Roche has be

    Watch Video
  • Where are they now? EpiAxis Therapeutics channels successes into scientific and business development

    Where are they now? EpiAxis Therapeutics channels successes into scientific and business development

    EpiAxis Therapeutics is channeling its success at BioPharm America™’s Startup Day into success at the business and scientific levels. Since finishing first for best “investment pitch quality and...

    Read
  • ChinaBio® Partnering Forum 2017: Funding drug development in China through VCs and partnerships1:01:21

    ChinaBio® Partnering Forum 2017: Funding drug development in China through VCs and partnerships

    Western and China companies are leveraging the significant funding and support available in China to develop their assets more cost effectively and efficiently. 2016 set another record in VC funds rai

    Watch Video
  • ChinaBio® Partnering Forum 2017: Rapid change: Good times for pharma?56:06

    ChinaBio® Partnering Forum 2017: Rapid change: Good times for pharma?

    Everything in China seems to be on the fast track. This is especially true in the pharma industry, where new announcements affecting regulations, pricing, and reimbursement are occurring on nearly a d

    Watch Video
  • Biotech Startups: Land and conduct a successful investor meeting

    Biotech Startups: Land and conduct a successful investor meeting

    Biotech startup companies face many challenges, but one of the most common is landing and conducting meetings with potential investors. The following are pieces of advice from investors on what...

    Read
  • Where are they now? Cocoon Biotech planning tox studies

    Where are they now? Cocoon Biotech planning tox studies

    Recognition from a high profile organization like the BioPharm America™ conference has been tremendous for Cocoon,” Ailis Tweed-Kent, MD, founder and CEO of Cocoon Biotech says. Winning the...

    Read
  • Where are they now? For Virvio, it’s all about visibility

    Where are they now? For Virvio, it’s all about visibility

    When Virvio participated in BioPharm America™’s Startup Day pitch contest in 2016, the company had been operational less than one year. It had three employees and was operating under grants from...

    Read
  • How can startup companies get noticed by potential investors and partners?1:22

    How can startup companies get noticed by potential investors and partners?

    Access the industry's premier life science partnering event, BioPharm America™ in Boston September 26–27, 2017, to connect with strategic partners and get your innovation funded. No other event combin

    Watch Video
  • Where to start: How to gain a foothold in the China biopharmaceutical market

    Where to start: How to gain a foothold in the China biopharmaceutical market

    The China pharmaceutical market has come of age. With record breaking investments in innovative companies, support from the CFDA, and new product approvals pending, China has entered a new age as...

    Read
  • BIO-Europe Spring® 2017: Imanova trims Phase I and IIa trial timelines and costs9:24

    BIO-Europe Spring® 2017: Imanova trims Phase I and IIa trial timelines and costs

    Dr. Kevin Cox, CEO of Imanova, the UK-based translational biomedical imaging company, explains to Scrip’s Mike Ward how his company can help biotechs and pharma firms cut the cost of Phase I and IIa t

    Watch Video
  • BIO-Europe Spring® 2017: Sinergium provides gateway to Latin American vaccine and biologics markets8:34

    BIO-Europe Spring® 2017: Sinergium provides gateway to Latin American vaccine and biologics markets

    With the Latin American vaccines market forecast to more than quadruple in size from just over USD 150 million to 2015 to just under USD 700 million in 2020, opportunities abound for both homegrown bu

    Watch Video
  • Tissue regeneration: A vital area within regenerative medicine

    Tissue regeneration: A vital area within regenerative medicine

    Guest post by Patricia Reilly, M.S., Head of Intelligence Alliances and Unification, Pharma Intelligence and Nancy Dvorin, Executive Editor, In Vivo Cell and gene therapies often get the lion’s...

    Read
  • loading
    Loading More...